Marco Allinovi

28PUBLICATIONS
91CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityInfant and child healthNeonatologyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jul 24, 2026
Potential Mechanisms of Partial/Transient Response or Resistance to Daratumumab Therapy: A Focus on Anti-Daratumumab Antibodies and Urinary Daratumumab Loss.

|Jul 23, 2026
Anti-podocin and Anti-KIRREL1 Antibodies and Steroid Resistance, FSGS, and Disease Recurrence after Transplantation in Autoimmune Podocytopathies.

|Jan 30, 2026
Potential implications of subclinical hypervolemia, identified by a multiparametric approach, in causing left ventricular hypertrophy in clinically euvolemic children on dialysis: a prospective longitudinal pilot study.

Marco Allinovi, Valentina Querin, Silvia Menale

|Jan 08, 2026
Kidney Transplantation in Childhood-Onset ANCA-Associated Vasculitis: Long-Term Outcomes and Prognostic Factors.

Giorgio Trivioli, Marco Allinovi, Elio Di Marcantonio

|Nov 26, 2025
Looks like a neoplasm, belongs to amyloidosis, but is usually benign: localized amyloidosis. A long-term retrospective monocentric study.

Luca Malatesta, Marco Allinovi, Francesco Cappelli

|Sep 25, 2025
Antiproteinuric effect of SGLT2 inhibitors in non-diabetic glomerulopathies is dependent on body mass index.

Maria J Vargas-Brochero, Ilario Russo, Tommaso Mazzierli

Pageof 5

Frequent Collaborators

6 joint publications

Paola Romagnani

4 joint publications

Gianmarco Lugli

3 joint publications

Anna Julie Peired

3 joint publications

Federico Perfetto